Panophthalmitis From Candida auris

Letters17 December 2019Panophthalmitis From Candida aurisVinayak Shenoy, DO, Matthew Ballenberger, MD, Adam Prince, MD, and Stephen Maslak, MDVinayak Shenoy, DOLenox Hill Hospital, New York, New York (V.S., M.B., A.P., S.M.), Matthew Ballenberger, MDLenox Hill Hospital, New York, New York (V.S., M.B., A.P., S.M.), Adam Prince, MDLenox Hill Hospital, New York, New York (V.S., M.B., A.P., S.M.), and Stephen Maslak, MDLenox Hill Hospital, New York, New York (V.S., M.B., A.P., S.M.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/L19-0323 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: Candida auris was first identified in Japan in 2009, in material extracted from a patient's external ear canal (1). Since then, C auris reportedly has caused bloodstream, wound, and urinary and respiratory tract infections associated with nosocomial outbreaks on several continents (2).Objective: To increase clinicians' awareness that C auris may cause panophthalmitis.Case Report: A 30-year-old man presented with vision loss in his right eye. He had HIV infection and recently diagnosed syphilis. Several days before presentation, he noticed fatigue, right eye irritation, and a blind spot in the center of his visual field. Two days later, he ...References1. Satoh K, Makimura K, Hasumi Y, et al. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53:41-4. [PMID: 19161556] doi:10.1111/j.1348-0421.2008.00083.x CrossrefMedlineGoogle Scholar2. Connell PP, O'Neill EC, Fabinyi D, et al. Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye (Lond). 2011;25:66-72. [PMID: 20966972] doi:10.1038/eye.2010.145 CrossrefMedlineGoogle Scholar3. Schelenz S, Hagen F, Rhodes JL, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35. [PMID: 27777756] CrossrefMedlineGoogle Scholar4. Khan Z, Ahmad S, Al-Sweih N, et al. Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait. PLoS One. 2018;13:e0195743. [PMID: 29630658] doi:10.1371/journal.pone.0195743 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Lenox Hill Hospital, New York, New York (V.S., M.B., A.P., S.M.)Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L19-0323.This article was published at Annals.org on 10 September 2019. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byChallenges in the diagnosis and treatment of candidemia due to multidrug-resistant Candida aurisThe Menace of Candida auris Epidemic Amidst the COVID-19 Pandemic: A Systematic ReviewCandida auris and endogenous panophthalmitis: clinical and histopathological features 17 December 2019Volume 171, Issue 12Page: 941-943KeywordsAmphotericinCellulitisComputed axial tomographyMagnetic resonance imagingMouthResearch laboratoriesSaline solutionsUlcersVancomycinVision ePublished: 10 September 2019 Issue Published: 17 December 2019 Copyright & PermissionsCopyright © 2019 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...